Pluri Inc. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Pluri Inc. (PLUR) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 323.99 thousand shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-09-10
- Pluri Inc. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-12-31 was 255.35K shares.
- Pluri Inc. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2026 was 323.99K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | 323.99K shares 10-K · filed 2026-09-10 | |||
| 2026-03-31 | 423.75K shares 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 255.35K shares 10-Q · filed 2026-02-12 | 628.76K shares 10-Q · filed 2026-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |